Chemoinformaics analysis of 1,2-dimethoxy benzene
| Molecular Weight | 138.166 | nRot | 2 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 6 |
| Exact Molecular Weight | 138.068 | nRing | 1 |
| Solubility: LogS | -1.868 | nHRing | 0 |
| Solubility: LogP | 1.682 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 21.6319 |
| nHD | 0 | BPOL | 13.5041 |
| QED | 0.619 |
| Synth | 1.07 |
| Natural Product Likeliness | -0.181 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.082 |
| HIA | 0.003 |
| CACO-2 | -4.332 |
| MDCK | 0.0000294 |
| BBB | 0.867 |
| PPB | 0.706602 |
| VDSS | 1.403 |
| FU | 0.177482 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.946 |
| CYP2c19-inh | 0.655 |
| CYP2c19-sub | 0.883 |
| CYP2c9-inh | 0.052 |
| CYP2c9-sub | 0.825 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.914 |
| CYP3a4-inh | 0.086 |
| CYP3a4-sub | 0.508 |
| CL | 9.24 |
| T12 | 0.885 |
| hERG | 0.11 |
| Ames | 0.106 |
| ROA | 0.032 |
| SkinSen | 0.671 |
| Carcinogencity | 0.788 |
| EI | 0.983 |
| Respiratory | 0.279 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.910072 |